Spanish Version of Credibility and Expectancy Questionnaire in Patients With Musculoskeletal Injuries

Validation Study Clinical Trial

Official title:

Translation, Adaptation and Valitation of the Spanish Version of Credibility and Expectancy Questionnaire in Patiens With Musculoskeletal Injuries

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06260800
• Other study ID #: PI 23-3405
• Status: Recruiting
• Start date: January 8, 2024
• Est. completion date: November 30, 2024

Study information

• Verified date: February 2024
• Source: University of Valladolid
• Contact: Silvia Lahuerta Martín
• Phone: +34 620431438
• Email: silvia.lahuerta[@]uva.es
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Physiotherapy treatment of musculoskeletal injuries should be performed following the main clinical guidelines of person-centered care. Patients' perception of the abilities and facilities provided by physiotherapists boost a convenient therapeutic relationship. This relation is linked with more satisfaction and adherence during the treatment, as well as credibility and expectancy of the patient related to the treatment. Thus, Credibility and Expectancy questionnaire is normally used to assess that point. CEQ presents good psychometric properties when used in Physisiotherapy interventions, but there is not a spanish version of this questionaire.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 60
• Est. completion date: November 30, 2024
• Est. primary completion date: July 1, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Volunteer patients who are going to start physiotherapy treatment due to musculoskeletal injuries.

• Age above 18 years old.

• Understanding of the study purpose and signing the informed consent.

Exclusion Criteria:

• Patients with cognitive deprivation.

• Not able to fill in the questionnaires autonomously.

• Mother tongue different from Spanish.

Related Conditions & MeSH terms

• Validation Study

Intervention

Other:
• Validation CEQ
In initial assessment, EQ-5D-5L and HADS questionnaires were completed. After sessions 1 and 2, CEQ and WAI-S were filled. Finally, EQ-5D-5L was completed before the fourth session.

Locations

Country	Name	City	State
Spain	Silvia Lahuerta Martín	Soria

Sponsors (1)

Lead Sponsor	Collaborator
University of Valladolid

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Content validity	Credibility and Expectancy questionnaire (CEQ) must be completed, while registering the time used and the quality and the reading comprehension.	During the intervention: Session 1 and 2 treatment
Primary	Construct validity	Exploratory factor analysis (EFA) and confirmatory factorial analysis (CFA) were performed. For EFA Kaiser criterion >0.70 will be acceptable. For CFA, goodness of fit index and comparative fit index were calculated, where values up to 0.90 were acceptable.	During the intervention: session 1 and 2 treatment
Primary	Reliability	Credibility and Expectancy questionnaire (CEQ) reliability will be analised through internal consistency (alpha Cronbach > 0.70 recomended)) and test-retest (intraclass correlation coeficient >0.70 acceptable).	During the intervention: Session 1 and 2 treatment
Primary	Criterion validity	Comparing CEQ with a gold standard.	During the intervention: session 1 and 4 treatment.